Siesling S, Visser O, van Dijck J A A M, Coebergh J W W
Integraal Kankercentrum Stedendriehoek Twente, Lasondersingel 133, 7514 BP Enschede.
Ned Tijdschr Geneeskd. 2006 Nov 11;150(45):2490-6.
To provide insight into the changing nature and size of the cancer burden within The Netherlands.
Retrospective.
Data on incidence and death relating to various forms of cancer are calculated on the basis of registered data concerning the incidence (Netherlands Cancer Registration; NCR) of and death (Statistics Netherlands) from cancer in the Netherlands from 1989 until 2003.
From the start in 1989 up to 2003, more than one million new cases of cancer were registered with the NCR. The total number of new patients with a primary tumour increased from 56,335 in 1989 to 73,188 in 2003 (30%). The most frequently occurring tumours in 2003 were of the breast, colon, lung and prostate. The age standardized incidence rate for males and females combined, increased from 381 per 100,000 in 1989 to 400 per 100,000 person years in 2003 (+5%). There was an increase in breast, prostate, skin and oesophagus cancer, and also lung cancer in females. Major decreases were seen in lung cancer in males, as well as stomach, ovary and gallbladder cancer. The number of cancer deaths in the Netherlands increased from 35,420 in 1989 to 38,454 in 2003 (+8%). The age and sex standardized mortality rate declined from 234 per 100,000 in 1989 to 201 per 100,000 in 2003 (-14%).
Despite a slight increase in the incidence of cancer and an increase in mortality from lung cancer (in females), oesophageal cancer and melanomas, the death rate from cancer has dropped considerably. The changes in incidence and mortality may be explained by changes in lifestyle in the 1970s and 80s, in particular use of tobacco and alcohol. Also early detection and screening programmes have resulted in an increase in the incidence of tumours with a better prognosis, which has led to a decrease in mortality. The downward trend in mortality was also influenced by treatment-improving prognoses.
深入了解荷兰癌症负担的性质和规模变化。
回顾性研究。
基于1989年至2003年荷兰癌症发病率(荷兰癌症登记处;NCR)和死亡率(荷兰统计局)的登记数据,计算各种癌症的发病和死亡数据。
从1989年开始到2003年,NCR登记的癌症新病例超过100万例。原发性肿瘤新患者总数从1989年的56,335例增加到2003年的73,188例(增长30%)。2003年最常见的肿瘤是乳腺癌、结肠癌、肺癌和前列腺癌。男性和女性合并的年龄标准化发病率从1989年的每10万人381例增加到2003年的每10万人年400例(增长5%)。乳腺癌、前列腺癌、皮肤癌和食管癌以及女性肺癌的发病率有所上升。男性肺癌以及胃癌、卵巢癌和胆囊癌的发病率大幅下降。荷兰的癌症死亡人数从1989年的35,420人增加到2003年的38,454人(增长8%)。年龄和性别标准化死亡率从1989年的每10万人234例下降到2003年的每10万人201例(下降14%)。
尽管癌症发病率略有上升,肺癌(女性)、食管癌和黑色素瘤的死亡率有所增加,但癌症死亡率已大幅下降。发病率和死亡率的变化可能归因于20世纪70年代和80年代生活方式的改变,特别是烟草和酒精的使用。此外,早期检测和筛查计划导致预后较好的肿瘤发病率增加,从而降低了死亡率。死亡率的下降趋势也受到治疗改善预后的影响。